LABORATORIOS FARMACEUTICOS ROVI SA
LABORATORIOS FARMACEUTICOS ROVI S.../ ES0157261019 /
LABFF
|
01/07/2024 21:24:23
|
Chg.
-
|
Volume |
Bid- |
Ask- |
Market Capitalization |
Dividend Y. |
P/E Ratio |
|
90.6100USD
|
-
|
100
Turnover: 9,061 |
-Bid Size: - |
-Ask Size: - |
3.55 bill.USD |
- |
- |
Business description
Laboratorios Farmaceuticos Rovi, S.A., headquartered in Madrid, Spain, develops, manufactures, and markets pharmaceutical products globally. Key products include Enoxaparin Rovi, Hibor, and Iomeron. Rovi also offers contract manufacturing services for prefilled syringes, vials, and more. Founded in 1946, it operates across cardiology, women's health, pain management, and other therapeutic areas.
Management board & Supervisory board
| CEO |
| Juan López-Belmonte Encina |
| Management board |
| - |
| Supervisory board |
| Iván López-Belmonte Encina, Fátima Báñez García, Marina del Corral Téllez, Marcos Peña Pinto, Teresa Corzo Santamaría, Gabriel Núñez Fernández, Ignacio Zarzalejos Toledano, Juan López-Belmonte Encina, Javier López-Belmonte Encina |
Company data
| Name: |
Laboratorios Farmaceuticos Rovi, S.A. |
| Address: |
Calle José Isbert, 2,28223 Pozuelo de Alarcón (Madrid) |
| Phone: |
+34-91-021-3000 |
| Fax: |
- |
| E-mail: |
rovi@rovi.es
|
| Internet: |
https://www.rovi.es/ |
| Industry: |
Healthcare |
| Sector: |
Pharmaceutical Industry |
| Sub sector: |
Pharmaceuticals |
| End of financial year: |
31/12 |
| Free Float: |
35.68% |
| IPO date: |
- |
Investor relations
| Name: |
- |
| IR phone: |
+34-91-244-4422 |
| IR Fax: |
- |
| IR e-mail: |
ir@rovi.es
|
